检索

The development of a screening questionnaire to improve the early detection of pulmonary arterial hypertension

Valieva Z., Valeeva E., Glukhova S., Martynyuk T., Chazova I.

(Rus)

卷 18, 编号 1 (2021)

Specificity of the effect of double fractures of the rhythmogram on the daily variability of the sinus rhythm in patients with pulmonary and arterial hypertension

Sobolev A., Ryabykina G., Kozhemyakina E.

(Rus)

卷 14, 编号 4 (2017)

Clinical Manual for Diagnosis, Prevention and Treatment of Cardiovascular Complications of Cancer Therapy. Parts II-V

Chazova I., Tyulyandin S., Vitsenia M., Poltavskaya M., Gilyarov M., Martynyuk T., Ovchinnikov A., Panchenko E., Fedotkina Y., Stenina M., Trophimova O., Ageev F.

(Rus)

卷 16, 编号 1 (2019)

Obesity and hypertension: the role of criteria

Tsygankova D., Krivoshapova K., Maksimov S., Indukaeva E., Shapovalova E., Artamonova G., Barbarash O.

(Rus)

卷 6, 编号 3 (2009)

Atherosclerotic stenos of renal arteries at patients with diabetes mellitus and arterial hypertension.

Fomin V., Moiseev S., Shvetsov M., Mukhin N.

Arterial hypertension and treatment of non steroidal anti-inflammatory drugs: advantage amlodipin

Ezhov M., Yezhov M.

卷 14, 编号 3 (2017)

Interaction of antihypertensive drugs and rosuvastatin: focus on safety, efficiency and prospects

Luchinina E., Kompaniets O., Kizhvatova N.

(Rus)

卷 14, 编号 4 (2017)

Features of the use of torasemide in arterial hypertension

Baryshnikova G., Chorbinskajya S.

(Rus)

卷 14, 编号 1 (2017)

Arterial hypertension treatment changes in Yaroslavl region: results obtained after 4 years of complex program of regional healthcare system’s improvement implementation

Mozheyko M., Vigdorchik A., Eregin S., Danilenko N., Klimovskaya I., Ramanathan K., Hughes D.

(Rus)

卷 13, 编号 2 (2016)

Chronotherapy’s opportunities of a fixed combination of perindopril 10 mg/indapamide 2.5 mg in patients with a lack of night reduction in blood pressure

Aksenova A., Elfimova E., Litvin A., Chazova I.

(Rus)

卷 12, 编号 4 (2015)

Association of clinical and genetic factors with left ventricular hypertrophy in hypertension among the indigenous population Mountain Shoria

Mulerova T., Kuzmina A., Chigisova A., Voropaeva E., Maksimov V., Voevoda M., Ogarkov M.

(Rus)

卷 12, 编号 2 (2015)

The recommendations review concerning the maintenance of patients with arterial hypertension: evidence and expert opinions

Samorodskaya I., Boitsov S.

(Rus)

Possibilities ARB II (sartans) in hypertensive patients

Morozova T., Andrushchishina T., Gontarenko S.

(Rus)

Optimization of drug therapy of coronary heart disease and arterial hypertension: choice angiotensin-converting enzyme inhibitors

Trukhan D., Tarasova L.

(Rus)

Rational therapy of hypertension with concomitant ischemic heart disease

Chukaeva I., Orlova N., Soloveva M.

(Rus)

Riociguatas the first innovative guanylatecyclase stimulators class drugs for pulmonary arterial hypertension patients treatment

Chazova I., Martynyuk T.

Modern approaches to combined therapy of arterial hypertension

Napalkov D., Zhilenko A.

Additional possibilities of antihypertensive therapy for metabolic syndrome

Kislyak O., Pokhilchenko M.

Torasemide: additional benefits for postmenopausal women with arterial hypertension

Tkacheva O., Runikhina N., Sharashkina N.

卷 10, 编号 1 (2013)

Hypertension treatment: Is there a place for b-adrenoblockers?

Minushkina L.

卷 9, 编号 4 (2012)

The abilities of losartan in angioprotection in hypertensive patients with hyperuricemia

Nedogoda S., Ledyaeva A., Chumachok E., Tsoma V., Salasyuk A.

卷 6, 编号 2 (2009)

Amlodipin in the treatment of arterial hypertension

Galyavich A.

卷 3, 编号 1 (2006)

Lechenie patsienta s arterial'noy gipertenziey i gipertrofiey levogo zheludochka

Chazova I., Ratova L., Ataullakhanova D.

卷 1, 编号 2 (2004)

Kombinirovannaya terapiya arterial'noy gipertenzii s pozitsiy profilaktiki serdechno-sosudistykh oslozhneniy i patogeneza

Boytsov S.

卷 18, 编号 1 (2021)

Expert consensus. Effect of antihypertensive therapy on cognitive functions

Ostroumova O., Parfenov V., Ostroumova T., Yakhno N., Chazova I., Bogolepova A., Galyavich A., Geraskina L., Emelin A., Zakharov V., Kislyak O., Kulesh A., Levin O., Podzolkov V., Privalova E., Shikh E.

(Rus)

Radiofrequency denervation of the renal arteries in patients with resistant arterial hypertension: 3 years of observation experience

Savelyeva N., Zherzhova A., Mikova E., Gapon L., Kolunin G., Krinochkin D.

(Rus)

Role of fixed combinations in modern treatment of arterial hypertension: new or well overlooked old?

Adasheva T., Samorukova E., Zadionchenko V., Laricheva K.

(Rus)

Candesartan in the prevention of cardiovascular catastrophes: emphasis on the pre-vention of stroke

Drapkina O., Dikur O.

Renovaskulyarnaya arterial'naya gipertenziya: diagnostika i lechenie

Danilov N., Chazova I., Savchenko A.

Metabolic and antihypertensive effects of moxonidine and moxonidine plus irbesartan in patients withtype 2 diabetes mellitus and mild hypertension:a sequential, randomized, double-blind clinical trial

Giuseppe Derosa -., Arrigo FG Cicero -., Angela D'Angelo -., Elena Fogari -., Sibilla Salvadeo -., Alessia Gravina -., Ilaria Ferrari -., Raffaella Fassi -., Roberto Fogari -.

卷 6, 编号 3 (2009)

Whether all ACE inhibitors enzyme are identical? Focus on zofenopril.

Ratova L., Chazova I.

卷 15, 编号 2 (2018)

Stroke prevention in patients with atrial fibrillation and comorbidities

Ostroumova O., Voevodina N., Guseva T., Pavleeva E., Piksina G., Goloborodova I.

(Rus)

卷 15, 编号 1 (2018)

Pulmonary hypertension: reasonable selection of specific therapy

Karoli N., Sazhnova S., Rebrov A.

(Rus)

卷 14, 编号 1 (2017)

Treatment of patients with high cardiovascular risk: a modern view on combined therapy

Blankova Z., Aslanian N., Smolianinova N., Ageev F.

(Rus)

卷 13, 编号 3 (2016)

Control of cardiovascular risk in patients with diabetes

Zhernakova Y., Chazova I.

(Rus)

卷 13, 编号 2 (2016)

Diuretics in combination antihypertensive therapy: focus on forecast

Chazova I., Martyniuk T.

(Rus)

卷 12, 编号 1 (2015)

Medical and social risk factors for arterial hypertension in coal miners

Indukaeva E., Makarov S., Ogarkov M.

(Rus)

卷 12, 编号 2 (2015)

Fibromuscular dysplasia as the cause of malignant renovascular hypertension in a newborn

Albot V., Dolgikh V., Gvak G., Pogodina A.

(Rus)

Nebivolol for treatment patients with arterial hypertension

Mikheeva O., Komisarenko I.

(Rus)

Effect of sildenafil on clinical evidence and hemodynamic parameters in patients with pulmonary arterial hypertension, associated withsystemic rheumaticdiseases

Volkov A., Udkina N., Kurmukov I., Nikolaeva Y., Nasonov Y.

(Rus)

The comparative analysis of therapy by «typical practice» and the fixed combination perindopril and indapamide an arterial hypertension with kidney insufficiency

Shiganov S., Baev V., Shulbayev A.

卷 9, 编号 4 (2012)

Iloprost for acute tests in patients with pulmonary arterial hypertension

Belyatko E., Danilov N., Matchin Y., Martynyuk T., Chazova I.

卷 9, 编号 4 (2012)

Diuretics in arterial hypertension: a focus on torasemide

Baryshnikova G., Stepanova I.

卷 6, 编号 2 (2009)

Efficacy of metoprolol in treatment and preventive of cardiovascular diseases

Chazova I., Ratova L., Ratova L., Chazova I.

卷 3, 编号 1 (2006)

Blokatory retseptorov k angiotenzinu II v lechenii diabeticheskoy nefropatii s pozitsiy dokazatel'noy meditsiny

Shestakova M.

卷 1, 编号 1 (2004)

Antigipertenzivnaya effektivnost' valsartana, vliyanie na sostoyanie tsentral'noy gemodinamiki i mikrotsirkulyatsii: vzglyad s pozitsiy organoprotektsii

Podzolkov V., Bulatov V., Son E., Makolkin V.

卷 18, 编号 2 (2021)

Prevalence of risk factors for arterial hypertension among draft age youth

Uvarovskaia B., Mel’nik M., Kniazeva S.

(Rus)

卷 17, 编号 2 (2020)

Clinical guidelines on arterial hypertension diagnosis, treatment and prevention in children and adolescents

Aleksandrov A., Kisliak O., Leontyeva I.

(Rus)

Target blood pressure levels in patients with arterial hypertension and frailty

Ostroumova O., Cherniaeva M., Morozov A.

(Rus)

Three calcium antagonists: a place of everyone in treatment arterial hypertension (ALTERNATIVE study)

Chazova I., Ratova L.

Diuretics in treatment of patients with arterial hypertension

Chazova I., Ratova L.

Ramipril - angiotensin converting enzyme ingibitor with a wide spectrum of therapeutic action

Preobrazhenskiy, D., Preobrazhensky D., Vyshinskaja I., Vyshinskaya I.

卷 15, 编号 4 (2018)

Evaluation of effectiveness and safety of the first Russian-manufactured generic bosentan use in patients with pulmonary arterial hypertension

Arkhipova O., Gratsianskaya S., Martynyuk T.

(Rus)

卷 15, 编号 3 (2018)

The progression of carotid vascular remodeling risk factors in patients with arterial hypertension

Pavlova O., Korobko I., Nechesova T., Liventseva M., Zatoloka N., Kovsh E., Ogurtsova S., Mrochek A.

(Rus)

卷 14, 编号 2 (2017)

Clinical-pharmacological priorities in the election of blockators of the renin-angiotenzine system and diuretics in patients with uncompleted hypertension

Ponomareva A., Ketova G., Kompaniets O.

(Rus)

卷 14, 编号 2 (2017)

Achievement of the main goals of therapy by using of a triple fixed combination of amlodipine, indapamide and perindopril (Co-Dalneva®) in patients with arterial hypertension

Chukaeva I., Spiryakina Y., Glibko K., Orlov D., Bayramova A., Logunova I.

(Rus)

卷 13, 编号 4 (2016)

A fixed combination of amlodipine and losartan: effectiveness and safety in abnormal weather conditions in patients with arterial hypertension

Ageev F., Smirnova M., Fofanova T., Blankova Z., Vitsenya M., Tsybulskaya T., Neverova E., Samsonova N.

(Rus)

卷 13, 编号 1 (2016)

Current possibilities of nuclear imaging in arterial hypertension

Ansheles A., Sergienko V.

(Rus)

卷 12, 编号 3 (2015)

Gender differences renin-angiotensin-aldosterone system and its relation to humoral factors in patients with arterial hypertension

Dadashova G.

(Rus)

卷 12, 编号 2 (2015)

Possibilities of electrocardiographic and decartographic parametersin the diagnosis of right ventricular overload in patients with pulmonary arterial hypertension

Sakhnova T., Blinova E., Saidova M., Yurasova E., Arkhipova O., Martynyuk T., Trunov V., Aydu E., Chazova I.

(Rus)

Perindopril - angiotensin-converting enzyme inhibitor is approved for usage

Napalkov D.

(Rus)

Peculiarity of medical management of patients with arterial hypertension after liver transplantation

Kosmacheva Y., Babich A.

(Rus)

Modern opportunities of monotherapy in patients with arterial hypertension associated with comorbid disorders

Gorokhovskaya G., Yun V.

(Rus)

卷 11, 编号 2 (2014)

Efficacy and safety of amlodipine and perindopril (Prestance) fixed combination in patients with arterial hypertension during the summer heat

Chazova I., Ageev F., Smirnova M., Ageeva N., Fofanova T., Svirida O., Mikhailov G., Levin A., Revich B.

(Rus)

Practical aspects of fixed combinations in the treatment of hypertension

Ogarkov M., Baranova M., Skripchenko A.

(Rus)

卷 10, 编号 3 (2013)

Rol' trimetazidina v regulyatsii energeticheskogo metabolizma miokarda pri serdechno-sosudistykh zabolevaniyakh

Dorofeeva G., Dorofeev I., Trofimova Y., Manerova O.

Rational pharmacotherapy of hypertension. Urapidil potential

Morozova T., Andruschishina T., Shmarova D.

Effect of angiotensin II receptor antagonists on left ventricular hypertrophy, vascular elasticity, and lipid and carbohydrate metabolic parameters in metabolic syndrome

Nedogoda S., Salasyuk A., Chalyabi T., Barykina I., Pocheptsov D., Ledyaeva A., Tsoma V., Chumachek E.

Combined pharmacotherapy for arterial hypertension: a view through the 2013 clinical practice guidelines

Rodionov A.

卷 3, 编号 2 (2006)

Terapiya irbesartanom bol'nykh sakharnym diabetom tipa 2: metabolicheskie effekty i vliyanie na perfuziyu golovnogo mozga

Mamyrbaeva K., Mychka V., Masenko V., Sergienko V., Chazova I.

卷 17, 编号 4 (2020)

Gender-age peculiarities of smoking and diabetes mellitus role in the development of myocardial infarction in patients with arterial hypertension

Aksenova A., Oshchepkova E., Orlovsky A., Chazova I.

(Rus)

Risk factors for falls in patients with arterial hypertension

Khovasova N., Naumov A., Tkacheva O., Moroz V.

(Rus)

The modern treatment of cardiovascular diseases with b-blockers - focus on the nebivolol.

Evdokimova A., Ol'khin V., Evdokimov V., Zolotareva E., Khadzegova A.

Metabolic syndrome

Mychka V., Chazova I., Mychka V., Chazova I.

Up-to date view on -blocker in treatment of arterial hypertension with heart failure

Gorokhovskaya G., Petina M., Nikolau E., Martynov A., Gorohovskaja G., Petina M., Nikolau E., Martynov A.

卷 15, 编号 4 (2018)

Organoprotection with arterial hypertension 2-3 degrees

Afonicheva I., Melnik M., Knyazeva S., Kazyulin A.

(Rus)

卷 14, 编号 3 (2017)

The influence of Losartanum and Amlodipinum fixed combination use on cardiovascular complications risk factors seasonal variability in patients with arterial hypertension

Smirnova M., Fofanova T., Ageev F., Blankova Z., Vicenia M., Barinova I.

(Rus)

卷 12, 编号 4 (2015)

Myocardial ischemia in patients with pulmonary arterial hypertension

Arkhipova O., Martyniuk T., Valeeva E., Ryabykina G., Samoylenko L., Sergienko V., Chazova I.

(Rus)

卷 12, 编号 1 (2015)

Treatment with perindopril in patients with arterial hypertension: improving compliance

Anikin G., Minina E., Andreevskaya E.

(Rus)

卷 12, 编号 1 (2015)

Functional state of kidneys and arterial hypertension among indigenous and nonindigenous residents of Mountain Shoria

Ogarkov M., Filimonov E., Mulerova T., Kuzmina A.

(Rus)

Arterial hypertension and brain damage. New targets of therapy

Yanishevskiy S., Mirnaya D., Andreyev R.

(Rus)

Pleiotropic features of dihydropyridine calcium channel antagonists

Anikin G.

(Rus)

Modernization of hypertension treatment in the Yaroslavl region: interim results of the yearly comprehensive program for modernization of the regional healthcare system

Mozheyko M., Eregin S., Vigdorchik A., Klimovskaia I., Riahi F., Hughes D.

(Rus)

卷 11, 编号 2 (2014)

National questionnaire of treatment compliance:testing and application in outpatient practice

Fofanova T., Ageev F., Smirnova M., Svirida O., Kuzmina A., Thostov A., Nelyubina A.

(Rus)

Aldosterone synthase gene polymorphism in patients with hypertension combined ischemic heart disease with in various left ventricular mass

Yahontov D., Derisheva D., Gulyaeva L.

(Rus)

The effects of climate in patients with arterial hypertension, including in combination with chronic obstructive pulmonary disease and/or bronchial asthma

Chazova I., Ratova L., Dolgusheva Y., Nazarov B., Agapova O., Sivakova O., Galitsin P., Rvacheva A., Kuznetsova T., Beilina V., Tkachev G., Kaznacheeva E., Zykov K.

Legochnaya arterial'naya gipertenziya: na puti ot ratsional'noy diagnostiki k vyboru effektivnoy lekarstvennoy terapii

Chazova I., Martynyuk T.

The place of Indapamide retard in the treatment of patients with left ventricular dysfunction and preserved systolic function in the presence of arterial hypertension

Tereshchenko S., Zhirov I.

卷 6, 编号 2 (2009)

Vozmozhnosti telmisartana v ANGIO- i KArdioprotektsii i uluchshenii pokazateley uglevodnogo obmena pri narushenii tolerantnosti k glyukoze

Nedogoda S., Barykina I., Brel' U., Chalyabi T., Mazina G., Podol'skaya E., Ledyaeva A.

卷 3, 编号 2 (2006)

Opredeleno li mesto beta-adrenoblokatorov pri lechenii arterial'noy gipertonii?

Makolkin V.